欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号LT/H/0188/001
药品名称Mastromycin 500 mg
活性成分
    • clarithromycin lactobionate 500.0 mg
剂型Powder for concentrate for solution for infusion
上市许可持有人Zenthique Limited The Fort, Level 2 Hardrocks Business Park, Burmarrad Road Naxxar NXR 6345 Malta
参考成员国 - 产品名称Lithuania (LT)
Resthizen 500 mg milteliai infuzinio tirpalo koncentratui
互认成员国 - 产品名称
    • Malta (MT)
      Mastromycin 500mg powder for concentrate for solution for infusion
许可日期2023/09/06
最近更新日期2023/09/06
药物ATC编码
    • J01FA09 clarithromycin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase